E4Z: Baloxavir acid
E4Z is a Ligand Of Interest in 6FS6 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 6FS6_E4Z_C_903 | 59% | 10% | 0.136 | 0.918 | 1.75 | 2.57 | 6 | 7 | 0 | 0 | 100% | 1 |
| 6FS6_E4Z_F_903 | 57% | 9% | 0.131 | 0.906 | 1.85 | 2.63 | 6 | 8 | 0 | 0 | 100% | 1 |
| 6FS6_E4Z_A_903 | 57% | 13% | 0.145 | 0.92 | 1.84 | 2.14 | 6 | 7 | 0 | 0 | 100% | 1 |
| 6FS6_E4Z_B_903 | 56% | 11% | 0.136 | 0.907 | 1.78 | 2.39 | 6 | 9 | 0 | 0 | 100% | 1 |
| 6FS6_E4Z_E_903 | 44% | 10% | 0.149 | 0.876 | 1.77 | 2.47 | 6 | 9 | 0 | 0 | 100% | 1 |
| 6FS6_E4Z_D_903 | 41% | 11% | 0.155 | 0.871 | 1.83 | 2.37 | 6 | 8 | 0 | 0 | 100% | 1 |
| 8T5W_E4Z_A_303 | 76% | 4% | 0.097 | 0.932 | 2.43 | 3.19 | 15 | 15 | 0 | 1 | 100% | 1 |
| 8T5V_E4Z_A_303 | 63% | 5% | 0.116 | 0.91 | 2.61 | 2.7 | 16 | 13 | 0 | 0 | 100% | 1 |
| 6FS7_E4Z_E_903 | 57% | 13% | 0.121 | 0.895 | 1.76 | 2.18 | 7 | 7 | 0 | 0 | 100% | 1 |
| 6FS8_E4Z_A_201 | 92% | 18% | 0.078 | 0.968 | 1.54 | 1.98 | 7 | 9 | 0 | 0 | 100% | 1 |
| 7KBC_E4Z_A_201 | 80% | 2% | 0.116 | 0.965 | 3 | 3.69 | 11 | 15 | 1 | 0 | 100% | 1 |
| 7KAF_E4Z_A_201 | 79% | 2% | 0.12 | 0.967 | 3.07 | 3.49 | 11 | 17 | 0 | 0 | 100% | 1 |
| 7K0W_E4Z_A_201 | 79% | 40% | 0.123 | 0.97 | 0.98 | 1.36 | 4 | 6 | 0 | 0 | 100% | 1 |
| 6FS9_E4Z_A_203 | 69% | 11% | 0.138 | 0.953 | 2 | 2.18 | 9 | 11 | 0 | 0 | 100% | 1 |
